Their analysis of tumor tissue from almost 2500 patients with pancreatic cancer revealed that those lacking mutations of the KRAS gene (KRAS WT) frequently harbored mutations of genes associated with various critical cellular functions. The gene discussed is KRAS; the disease is familial pancreatic carcinoma.